Truvian Sciences is developing an automated benchtop broad panel testing system on a “small sample of blood” to support which the company just raised $27.1 million
Truvian Sciences is developing an automated benchtop broad panel testing system on a “small sample of blood” to support which the company just raised $27.1 million